DTN 130: China's Biotech Industry on the Rise
Plus: DIY drones flood the skies, the end of Natcast, Christie's deletes NFT department, self-assembling silicon nanowires, exotic phase of matter on a quantum processor, and more.
China’s biotech industry is on the rise. Will it reshape US pharma?
“It’s faster and easier to run clinical trials in China than in the US, which means it’s also faster and easier for drug developers and investors to learn whether drug candidates will work in humans…The Chinese biomedical engine has hit an inflection point, churning out new molecules with best-in-class and first-in-class potential at a hasty clip. Once known for generics and me-too drugs, China’s biotech industry has recently begun to develop more innovative medicines for cancer, autoimmune diseases, and cardiometabolic conditions. This change is catching the eye of investors in the US and Europe—and raising concerns about the sustainability of the US biotech sector.”
- Natcast to lay off majority of its staff
- Tech companies show off for Trump’s ‘Golden Dome’
- How AI will change chip design
- Reality is ruining the humanoid robot hype
- US warns hidden radios may be embedded in solar-powered highway infrastructure
- NASA blocks Chinese citizens from working on space programs
- Zoox robotaxi launches in Las Vegas
- DIY drones are on the rise, and they’re more invisible than ever
- House passes NDAA, with $848B topline and protections for Ukraine aid
- Data center developers urge NRC to ‘unleash’ nuclear power
- Elon Musk brings Neuralink brain implants to Toronto in global first
- NOAA sends uncrewed miniature vessels to probe ocean storms
- AI is changing the grid. Could it help more than it harms?
- Navy taps four aerospace primes to design autonomous drone wingmen
- Department of War: Trump gives DoD ‘secondary’ name, awaiting congressional buy in
- Horizontal drilling powering zero-carbon baseload with geothermal
Swedish researchers built a bio-ink called “μInk” and use a 3D printer to create a skin structure filled with high-density cells. Photograph: Magnus Johansson/Linköping University.
Doctors typically rely on skin grafting to treat severe burns, but it doesn’t always yield successful results, especially if the dermis - the layer containing blood vessels and nerves - fails to regenerate. Skin rejuvenation can quickly escalate to a matter of life and death. Swedish researchers are now one step closer to solving this problem by using 3D printing to create artificial skin has blood vessels, which means it’s considered “living skin.” Researchers hope this artificial skin could provide the building blocks for the body to make the dermis itself. In a transplantation experiment with mice, the scientists confirmed that living cells grew inside the transplanted tissue fragments made from the artificial skin. New blood vessels also grew inside the graft, indicating that the conditions for long-term tissue fixation were met. (via Wired)
- A new way to control terahertz light for faster electronics
- Tiny chip can sort and count nanoplastics for better pollution monitoring
- Physicists demonstrate controlled expansion of quantum wavepacket in a levitated nanoparticle
- Butterfly wings inspire solution to impossible optics problem
- Nanobots play 'follow the leader' by chasing chemical trails in microfluidic device
- Many lonely people would prefer a robot over human interaction
- Cat whiskers inspire highly sensitive, next-generation wearable pressure sensors
- Cancer cells use backup routes to fuel their growth
- Novel hollow-core optical fiber transmits data faster with record low loss
- Circuits invisible to the naked eye: new technique shrinks microchips beyond current size limits
- Exotic phase of matter realized on quantum processor
- A new way to prevent icing problems for aircraft and drones
- Solid-state batteries get a boost with new protective coating
- Silicon nanowires self-assemble into macroscopic networks for advanced materials
- Narrow-linewidth laser on a chip sets new standard for frequency purity
- Robotics startup Medra raises $11M to automate labs
- Sophont raises $9.2M to build multimodal foundation models
- Apex raises $200M to accelerate satellite production
- UK startup Messium raises £3.3M to measure crop nitrogen from space
- Odyssey Therapeutics heralds $213M Series D to strengthen clinical portfolio
- Kriya gains $320M in Series D for gene therapy development
- Chinese CRISPR company YolTech raises $45M as it plans for first phase 3 study
- Dutch battery startup LeydenJar raises $15.2M for its silicon anode tech to compete with China
- PsiQuantum raises $1B to build million-qubit scale, fault-tolerant quantum computers
- Rendezvous Robotics raises $3M to build space infrastructure
- Asabys Partners leads €10M extension of SafeHeal’s oversubscribed Series C financing to accelerate commercialization of Colovac®
- Mistral AI raises 1.7B€ to accelerate technological progress with AI
- florrent raises $9.5M in funding to provide firm power at every level of the grid
- Astrus raises $8M to expedite AI-driven microchip design process
- Proxima Fusion extends Series A to €200M total funding as it accelerates into hardware execution
- Sapphire Technologies raises $18M in Series C funding to expand its manufacturing facility and market reach
- Phoenix AI startup Nuclearn secures $10.5M to expand nuclear operations platform
- QuEra Computing raises $230M to accelerate development of large-scale fault-tolerant quantum computers
- Scintil Photonics bags $58M to power next-gen AI data centers with optical chips
- Torus secures $200M to boost modular power plant deployments
- Ridge Biotechnologies raises $25M seed to advance AI-driven precision enzyme and drug design technology
- China biotech Epigenic raises $60M to test CRISPR epigenetic therapies
- Euclid raises $20M Series A led by Venrock to accelerate renewable energy projects with its AI-driven platform and services
- Elysian raises $6M seed to redefine insurance claims services with AI-native platform
- Octave Bioscience secures $35.6M to expand MS testing platform
- BoobyBiome raises £2.5M to protect breast milk’s microbiome and transform infant health
- NRG Therapeutics raises $67M Series B to deliver clinical data in Parkinson’s and proof of concept in ALS/MND
- Chinese surgical robot startup, Ronovo Surgical, raises $67M led by J&J venture arm
- Epigenic Therapeutics raises $60M in Series B to accelerate clinical development of epigenetic medicines
- Rapafusyn closes $44M Series A for molecular glue platform
- ACT-ion Battery Technologies, maker of cathode active materials for lithium-ion batteries, raises $4M
- Integra Therapeutics secures €10.7M to advance gene therapies
- Puro.earth raises $12M to scale high-integrity carbon removal market
- Cognition AI, the startup behind AI coding agent Devin, raises $400M to hit $10.2B valuation
- Space Dots raises $1.5M seed round to provide insights on orbital threats
- Nuclear startup Deep Fission goes public in a curious SPAC
- ReOrbit raises €45M Series A to take on Musk’s Starlink from Europe
- Tiberius raises $4.5M for defense-as-a-service
- Geothermal is too expensive, but Dig Energy raises $5M for its impossibly small drill rig might fix that
Putin says organ transplants could grant immortality. Not quite. / A pill to heal the brain could revolutionize neuroscience / Meet WindRunner: the massive plane that transports wind turbine blades / Ready Set Jet breaks the atmosphere with space-certified beauty / Clocks created from random events can probe 'quantumness' of universe / The new math of quantum cryptography / How China’s propaganda and surveillance systems really operate / From burner phones to decks of cards: NYC teens adjusting to the smartphone ban / Center for the alignment of AI alignment centers / An engineering history of the Manhattan Project / Doorbell prankster that tormented residents of apartments turns out to be a slug / Analog vs. digital: the race is on to simulate our quantum universe / The end of the American city / How to study people who are drunk / Christie's deletes digital art department / How the myth that nicotine causes cancer is hurting public health / The doomers who insist AI will kill us all / Why former NFL all-pros are turning to psychedelics / The dying dream of a decentralized web
HAUS specializes in public relations and creative services for deep tech startups.
